Oncology Institute files debt obligation with SEC
The company disclosed a debt obligation in an 8-K filing on August 21, 2026.
Oncology Institute, Inc. filed a Form 8-K with the SEC on August 21, 2026, disclosing a debt obligation.[1]
The filing covers items 1.01, 2.03, and 9.01, with a period ending on August 20, 2026.[1]
The company is incorporated in Delaware and operates in the services sector for offices and clinics of doctors of medicine.[2]
Oncology Institute, Inc. is listed on Nasdaq and OTC exchanges with tickers TOI, DFPH, and TOIIW.[2]
In a prior 10-Q filing dated August 6, 2026, the company disclosed a going concern.[3]